Cemiplimab 350 mg i.v. on day 1 of every 21 days cycle for 2 cycles
NeoMatryx
Phase 2 small_molecule active
Quick answer
Cemiplimab 350 mg i.v. on day 1 of every 21 days cycle for 2 cycles for Merkel Cell Carcinoma, Stage I is a Phase 2 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Merkel Cell Carcinoma, Stage I
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active